Annual Report 2019/20

To our shareholders

Letter to shareholders

Following on from its strong growth momentum over the last two years, Sonova performed well above expectations until mid-March, when the global health and economic crisis resulting from the COVID-19 pandemic severely affected the Group’s business activities. Through its market and innovation leadership, Sonova remains well positioned to benefit from the expected recovery of demand when the situation eases.

Sales

Group sales were 2,917 million, an increase of 8.7% in local currencies or 5.6% in Swiss francs. This was driven both by organic growth and bolt-on acquisitions.

EBITA

621

CHFmillion

+10.4 in local currencies

The adjusted Group EBITA reached CHF 620.8 million, up 10.4% in local currencies or 4.5% in Swiss francs. As reported, Group EBITA reached CHF 554.3 million, an increase of 1.0% in local currencies vs. the prior year.

Key figures

Salesin CHF m

Sales by regionsin 2019/20 in %

Adjusted EBITAin CHF m

Adjusted EPSin CHF

Operating Free Cash Flowin CHF m

Number ofemployees

Feature Story

“Being able to hear makes me feel alive”

Natália Martins is a professional volleyball player who wears hearing aids made by Sonova brand Phonak. Having worn hearing instruments since losing her hearing in childhood, she is able to interact freely with the outside world and has even secured a place on the Brazilian national team.